President of Vantage BioTrials Interviewed by Pharmaboardroom on the State of Clinical Trials in Canada
Vantage BioTrials’ President, Vatche Bartekian, was recently interviewed by Pharmaboardroom on ways that the company focuses on operational excellence with a lean and holistic approach to each project and how they continually advocate for greater visibility for Canada on the international stage and an increase in collaboration within the pharmaceutical industry and regulatory bodies.
“What we can observe in Canada is a very diverse CRO landscape, in which each player has found its own specialty.”
In this in depth interview with Bartekian, you will discover how Vantage BioTrials differentiates itself with its business model from other CROs, some of the the challenges facing CROs as well as advantages in conducting clinical trials in Canada, the company’s approach to team management and leadership and the evolution of leadership roles within the Canadian life sciences ecosystem.
To read more about this compelling interview please click here.
Founded in 2007, Vantage BioTrials is a privately-held Contract Research Organization (CRO) that provides Phase I-IV clinical trial management services and implements Risk-Based Management through the use of Quality by Design (QbD) methodologies, all delivered to international pharmaceutical, biotechnology, generic pharmaceutical and medical device companies.